1. Home
  2. NISN vs STTK Comparison

NISN vs STTK Comparison

Compare NISN & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NISN
  • STTK
  • Stock Information
  • Founded
  • NISN 2005
  • STTK 2016
  • Country
  • NISN China
  • STTK United States
  • Employees
  • NISN N/A
  • STTK N/A
  • Industry
  • NISN Metal Fabrications
  • STTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • NISN Industrials
  • STTK Health Care
  • Exchange
  • NISN Nasdaq
  • STTK Nasdaq
  • Market Cap
  • NISN 46.0M
  • STTK 54.4M
  • IPO Year
  • NISN 2016
  • STTK 2020
  • Fundamental
  • Price
  • NISN $4.79
  • STTK $1.08
  • Analyst Decision
  • NISN
  • STTK Hold
  • Analyst Count
  • NISN 0
  • STTK 3
  • Target Price
  • NISN N/A
  • STTK $2.00
  • AVG Volume (30 Days)
  • NISN 131.8K
  • STTK 329.4K
  • Earning Date
  • NISN 10-15-2024
  • STTK 11-14-2024
  • Dividend Yield
  • NISN N/A
  • STTK N/A
  • EPS Growth
  • NISN 12.54
  • STTK N/A
  • EPS
  • NISN 4.19
  • STTK N/A
  • Revenue
  • NISN $452,263,984.00
  • STTK $6,435,000.00
  • Revenue This Year
  • NISN N/A
  • STTK $313.04
  • Revenue Next Year
  • NISN N/A
  • STTK N/A
  • P/E Ratio
  • NISN $1.23
  • STTK N/A
  • Revenue Growth
  • NISN 86.06
  • STTK 382.75
  • 52 Week Low
  • NISN $3.14
  • STTK $0.94
  • 52 Week High
  • NISN $22.55
  • STTK $11.76
  • Technical
  • Relative Strength Index (RSI)
  • NISN 25.07
  • STTK 40.71
  • Support Level
  • NISN $5.40
  • STTK $1.07
  • Resistance Level
  • NISN $6.11
  • STTK $1.38
  • Average True Range (ATR)
  • NISN 0.74
  • STTK 0.13
  • MACD
  • NISN -0.06
  • STTK 0.01
  • Stochastic Oscillator
  • NISN 0.24
  • STTK 9.09

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

Share on Social Networks: